1. Targeting of C‐type lectin‐like receptor 2 or P2Y12 for the prevention of platelet activation by immunotherapeutic CpG oligodeoxynucleotides: reply. (18th November 2017) Authors: Delierneux, C.; Donis, N.; Servais, L.; Wéra, O.; Lancellotti, P.; Oury, C. Journal: Journal of thrombosis and haemostasis Issue: Volume 16:Number 1(2018) Page Start: 185 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Targeting of C‐type lectin‐like receptor 2 or P2Y12 for the prevention of platelet activation by immunotherapeutic CpG oligodeoxynucleotides. (13th April 2017) Authors: Delierneux, C.; Donis, N.; Servais, L.; Wéra, O.; Lecut, C.; Vandereyken, M.; Musumeci, L.; Rahmouni, S.; Schneider, J.; Eble, J. A.; Lancellotti, P.; Oury, C. Journal: Journal of thrombosis and haemostasis Issue: Volume 15:Number 5(2017) Page Start: 983 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗